AJR Your Link to CME
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hausegger, K. A.
Right arrow Articles by Lammer, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hausegger, K. A.
Right arrow Articles by Lammer, J.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

American Journal of Roentgenology, Vol 170, 403-408, Copyright © 1998 by American Roentgen Ray Society

ARTICLES

Treatment of malignant biliary obstruction with polyurethane-covered Wallstents

KA Hausegger, S Thurnher, G Bodendorfer, CL Zollikofer, M Uggowitzer, C Kugler and J Lammer
Department of Radiology, University Hospital Graz, Austria.

OBJECTIVE: This study was undertaken to determine the safety, efficacy, and performance of polyurethane-covered Wallstents in the treatment of malignant biliary obstruction. SUBJECTS AND METHODS: This pilot study included 30 patients with malignant biliary obstruction. Palliative decompression of the obstructed bile duct was attempted with a polyurethane-covered Wallstent that is a prototype. Patients with hilar obstructions were excluded. All stents were inserted percutaneously. Kaplan-Meier analysis was used to determine stent patency. RESULTS: Effective biliary decompression was achieved in all patients initially. No acute stent-related complications occurred. The 30-day mortality rate was 20%. During follow-up, 11 stent occlusions occurred; therefore, the occlusion rate was 37%. The patency rates after 1, 3, 6, and 12 months were 96%, 69%, 47%, and 31%, respectively. Tumor growth through the stent covering that was proven both histologically and by biopsy observed in two patients, causing stent occlusion in one of them. Other reasons for stent occlusion were distal tumor ingrowth (n = 1) and biopsy-proven granulation tissue inside the stent (n = 2). Otherwise, the reasons for stent occlusion remained unclear. CONCLUSION: This prototype of a covered stent did not provide better results than did conventional uncovered stents in patients with malignant biliary obstruction. The covering did not effectively prevent tumor ingrowth in at least two patients. The stent also seems prone to premature occlusion.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 GutHome page
H Isayama, Y Komatsu, T Tsujino, N Sasahira, K Hirano, N Toda, Y Nakai, N Yamamoto, M Tada, H Yoshida, et al.
A prospective randomised study of "covered" versus "uncovered" diamond stents for the management of distal malignant biliary obstruction
Gut, May 1, 2004; 53(5): 729 - 734.
[Abstract] [Full Text] [PDF]

Home page
 RadiologyHome page
M. Schoder, P. Rossi, R. Uflacker, M. Bezzi, A. Stadler, M. A. Funovics, M. Cejna, and J. Lammer
Malignant Biliary Obstruction: Treatment with ePTFE-FEP- covered Endoprostheses—Initial Technical and Clinical Experiences in a Multicenter Trial
Radiology, October 1, 2002; 225(1): 35 - 42.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1998 by the American Roentgen Ray Society.